<DOC>
	<DOCNO>NCT01122173</DOCNO>
	<brief_summary>The purpose study assess safety performance Hansen Medical Sensei Robotic System Artisan Catheter use robotically manipulate RF ablation catheter treatment paroxysmal atrial fibrillation ( irregular heartbeat originate upper chamber heart ) .</brief_summary>
	<brief_title>Use Hansen Medical System Patients With Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>Subjects satisfy inclusion exclusion criterion treat RF ablation catheter Artisan guide catheter control Sensei X Robotic Catheter System . Subject follow period one year post ablation procedure . Follow visit time frame conduct 7-day , 30-day , 90-day , 180-day 365-day .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Subjects paroxysmal atrial fibrillation two spontaneously terminate episode atrial fibrillation , last long 30 second shorter 7 day , nine month prior enrollment . At least one episode must document EKG , TTM , Holter monitor , telemetry . 2 . Failure least one Class I IV antiarrhythmic drug ( AAD ) PAF evidence recurrent symptomatic PAF , intolerable side effect due AADs . AADs define Appendix B . 3 . Signed informed consent . 4 . Age 18 year old 5 . Able willing comply pre , post , followup testing requirement . 1 . Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause . 2 . Previous ablation atrial fibrillation . 3 . Atrial fibrillation episode last less 7 day terminate cardioversion . 4 . Previous valvular cardiac surgery procedure . 5 . Cardiac artery bypass graft procedure within previous 180 day . 6 . Previous septal defect repair . 7 . Expecting cardiac transplantation cardiac surgery within next 180 day . 8 . Coronary PTCA/stenting within previous 180 day . 9 . Documented leave atrial thrombus ultrasound image ( TEE ) . 10 . Documented history thromboembolic event within previous 365 day . 11 . Diagnosed atrial myxoma . 12 . Presence implant ICD . 13 . Presence permanent pacing lead . 14 . Significant restrictive , constrictive , chronic obstructive pulmonary disease disease malfunction lungs respiratory system chronic symptom . 15 . Significant congenital anomaly medical problem opinion investigator would preclude enrollment study . 16 . Women pregnant . 17 . Acute illness active infection time index procedure document either pain , fever , drainage , positive culture and/or leukocytosis ( WBC &gt; 11,000 mm3 ) antibiotic prescribe . 18 . Creatinine &gt; 2.5 mg/dl ( &gt; 221 µmol/L ) . 19 . Unstable angina . 20 . Myocardial infarction within previous 60 day . 21 . Left ventricular ejection fraction le 40 % 22 . History blood clot bleed abnormality . 23 . Contraindication anticoagulation medication . 24 . Contraindication compute tomography magnetic resonance imaging procedure . 25 . Life expectancy less 1 year . 26 . Enrollment another investigational study . 27 . Uncontrolled heart failure ( NYHA class III IV heart failure ) . 28 . Presence intramural thrombus , tumor , abnormality precludes catheter introduction positioning . 29 . Presence condition precludes vascular access . 30 . Left atrial size ≥ 50mm . 31 . INR great 3.0 within 24 hour procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Robotic Control</keyword>
	<keyword>Remote Control</keyword>
</DOC>